Qin Xiaodi, Strand Siri H, Lee Marissa R, Saraswathibhatla Aashrith, van IJzendoorn David G P, Zhu ChunFang, Vennam Sujay, Varma Sushama, Hall Allison, Factor Rachel E, King Lorraine, Simpson Lunden, Luo Xiaoke, Colditz Graham A, Jiang Shu, Chaudhuri Ovijit, Hwang E Shelley, Marks Jeffrey R, Owzar Kouros, West Robert B
bioRxiv. 2024 Sep 25:2023.10.10.561724. doi: 10.1101/2023.10.10.561724.
To identify mechanisms underlying the growth of ductal carcinoma in situ (DCIS) and properties that lead to progression to invasive cancer, we performed single-cell RNA-sequencing (scRNA-seq) on DCIS lesions and matched synchronous normal breast tissue. Using inferred copy number variations (CNV), we identified neoplastic epithelial cells from the clinical specimens which contained a mixture of DCIS and normal ducts. Phylogenetic analysis based on the CNVs demonstrated intratumoral clonal heterogeneity was associated with significant gene expression differences. We also classified epithelial cells into mammary cell states and found that individual genetic clones contained a mixture of cell states suggesting an ongoing pattern of differentiation after neoplastic transformation. Cell state proportions were significantly different based on estrogen receptor (ER) expression with ER-DCIS more closely resembling the distribution in the normal breast, particularly with respect to cells with basal characteristics. Using deconvolution from bulk RNA-seq in archival DCIS specimens, we show that specific alterations in cell state proportions are associated with progression to invasive cancer. Loss of an intact basement membrane (BM) is the functional definition of invasive breast cancer (IBC) and scRNA-seq data demonstrated that ongoing transcription of key BM genes occurs in specific subsets of epithelial cell states. Examining BM in archival microinvasive breast cancers and an model of invasion, we found that passive loss of BM gene expression due to cell state proportion alterations is associated with loss of the structural integrity of the duct leading to an invasive phenotype. Our analyses provide detailed insight into DCIS biology.
Single cell analysis reveals that preinvasive breast cancer is comprised of multiple genetic clones and there is substantial phenotypic diversity both within and between these clones. Ductal carcinoma in situ (DCIS) of the breast is a non-invasive condition commonly identified through mammographic screening. A primary diagnosis of DCIS carries little mortality risk on its own, but its presence is a risk factor for subsequent clonally related invasive breast cancer (IBC) (1-5).
为了确定导管原位癌(DCIS)生长的潜在机制以及导致其进展为浸润性癌的特性,我们对DCIS病变及配对的同期正常乳腺组织进行了单细胞RNA测序(scRNA-seq)。利用推断的拷贝数变异(CNV),我们从包含DCIS和正常导管混合物的临床标本中鉴定出肿瘤上皮细胞。基于CNV的系统发育分析表明,肿瘤内克隆异质性与显著的基因表达差异相关。我们还将上皮细胞分类为乳腺细胞状态,发现单个基因克隆包含多种细胞状态的混合物,这表明肿瘤转化后存在持续的分化模式。基于雌激素受体(ER)表达的细胞状态比例存在显著差异,ER-DCIS与正常乳腺中的分布更为相似,尤其是具有基底特征的细胞。利用存档DCIS标本中批量RNA-seq的反卷积分析,我们表明细胞状态比例的特定改变与进展为浸润性癌有关。完整基底膜(BM)的丧失是浸润性乳腺癌(IBC)的功能定义,scRNA-seq数据表明关键BM基因的持续转录发生在特定的上皮细胞状态亚群中。在存档的微浸润性乳腺癌和侵袭模型中检查BM,我们发现由于细胞状态比例改变导致的BM基因表达的被动丧失与导管结构完整性的丧失相关,从而导致侵袭性表型。我们的分析为DCIS生物学提供了详细的见解。
单细胞分析表明,浸润前乳腺癌由多个基因克隆组成,这些克隆内部和之间存在大量表型多样性。乳腺导管原位癌(DCIS)是一种通过乳腺钼靶筛查常见的非浸润性疾病。DCIS的初步诊断本身几乎没有死亡风险,但其存在是后续克隆相关浸润性乳腺癌(IBC)的危险因素(1-5)。